These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6950722)

  • 1. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH; Kessel D
    Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical mechanism for resistance to anthracycline antibiotics.
    Inaba M
    Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
    [No Abstract]   [Full Text] [Related]  

  • 4. Mode of action of calcium antagonists which alter anthracycline resistance.
    Kessel D; Wilberding C
    Biochem Pharmacol; 1984 Apr; 33(7):1157-60. PubMed ID: 6585204
    [No Abstract]   [Full Text] [Related]  

  • 5. Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
    Ganapathi R; Grabowski D; Schmidt H; Seshadri R; Israel M
    Biochem Biophys Res Commun; 1985 Sep; 131(2):912-9. PubMed ID: 2932108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
    Gupta S; Patel K; Singh H; Gollapudi S
    Cancer Lett; 1994 Jan; 76(2-3):139-45. PubMed ID: 7511983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of multidrug resistance by non-antitumor anthracycline analogs.
    Inaba M; Nagashima K; Sakurai Y; Fukui M; Yanagi Y
    Gan; 1984 Dec; 75(12):1049-52. PubMed ID: 6597118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daunorubicin accumulation by human myeloblasts varying in anthracycline resistance.
    Kessel D; Wilberding C; Karanes C; Ratanatharathorn V
    Cancer Lett; 1984 Oct; 24(3):305-9. PubMed ID: 6594191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
    Inaba M; Nagashima K
    Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular accumulation and disposition of aclacinomycin A.
    Egorin MJ; Clawson RE; Ross LA; Schlossberger NM; Bachur NR
    Cancer Res; 1979 Nov; 39(11):4396-400. PubMed ID: 498071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorus-containing metabolites in anthracycline-resistant murine leukemia P388 cells.
    Shiryaeva OA; Semenova NA; Sibeldina LA; Goncharova SA; Konovalova NP
    Neoplasma; 1992; 39(4):229-32. PubMed ID: 1436233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
    Demidova NS; Goncharova SA; Shiriaeva OA; Konovalova NP
    Eksp Onkol; 1989; 11(1):65-8. PubMed ID: 2924713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies on anthracycline haloderivatives.
    Facchinetti T; Geroni C; Fumagalli A; Giuliani FC
    Drugs Exp Clin Res; 1986; 12(8):657-61. PubMed ID: 3463498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to anthracyclines in P388/dx leukaemia cells.
    Bossa R; Dasdia T; Galatulas I; Zunino F
    Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restored in vitro sensitivity of adriamycin- and vincristine-resistant P388 leukemia with reserpine.
    Inaba M; Fujikura R; Tsukagoshi S; Sakurai Y
    Biochem Pharmacol; 1981 Aug; 30(15):2191-4. PubMed ID: 7295334
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
    Johnson RK; Howard WS
    Eur J Cancer Clin Oncol; 1982 May; 18(5):479-87. PubMed ID: 6956514
    [No Abstract]   [Full Text] [Related]  

  • 17. Flow cytometric monitoring of anthracycline transport in tumor cells.
    Krishan A
    Ann N Y Acad Sci; 1986; 468():80-4. PubMed ID: 3460483
    [No Abstract]   [Full Text] [Related]  

  • 18. Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia.
    Inaba M; Fujikura R; Sakurai Y
    Biochem Pharmacol; 1981 Jul; 30(13):1863-5. PubMed ID: 7271878
    [No Abstract]   [Full Text] [Related]  

  • 19. [Models of preclinical studies of anthracyclines].
    Fizames C
    Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular glutathione as a determinant of responsiveness to antitumor drugs.
    Romine MT; Kessel D
    Biochem Pharmacol; 1986 Oct; 35(19):3323-6. PubMed ID: 3464280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.